Log in

NASDAQ:HZNPHorizon Therapeutics Earnings Date, Estimates & History

$50.73
+1.98 (+4.06 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$48.95
Now: $50.73▼
$50.90
50-Day Range
$30.54
MA: $39.38▼
$49.56
52-Week Range
$22.69
Now: $50.73▼
$50.90
Volume2.98 million shs
Average Volume2.89 million shs
Market Capitalization$9.68 billion
P/E Ratio17.93
Dividend YieldN/A
Beta1.2

Earnings

Horizon Therapeutics (NASDAQ:HZNP) Earnings Information

Horizon Therapeutics last announced its quarterly earnings data on May 6th, 2020. The biopharmaceutical company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.21 by $0.19. The firm had revenue of $355.90 million for the quarter, compared to analyst estimates of $287.88 million. Its quarterly revenue was up 26.9% compared to the same quarter last year. Horizon Therapeutics has generated $1.94 earnings per share over the last year and currently has a price-to-earnings ratio of 17.9. Horizon Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 5th, 2020 based off prior year's report dates.

Horizon Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Horizon Therapeutics (NASDAQ:HZNP) Earnings Estimates

2020 EPS Consensus Estimate: $1.96
2021 EPS Consensus Estimate: $3.33
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203$0.26$0.36$0.32
Q2 20203$0.35$0.46$0.42
Q3 20203$0.50$0.59$0.54
Q4 20203$0.65$0.74$0.68
Q1 20212$0.59$0.66$0.63
Q2 20212$0.70$0.78$0.74
Q3 20212$0.81$0.93$0.87
Q4 20211$1.09$1.09$1.09

Horizon Therapeutics (NASDAQ HZNP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/5/2020
(Estimated)		       
5/6/20203/31/2020$0.21$0.40$0.95$287.88 million$355.90 millionTranscript
2/26/2020Q4 2019$0.42$0.56($1.72)$349.25 million$363.50 millionTranscript
11/6/2019Q3$0.50$0.64$1.19$330.60 million$335.50 millionTranscript
8/7/2019Q2 2019$0.38$0.52$1.07$296.27 million$320.60 millionListen
5/8/20193/31/2019$0.10$0.30$0.79$238.35 million$280.00 millionListen
2/27/2019Q4 2018$0.54$0.67$0.84$334.22 million$355.50 millionListen
11/7/20189/30/2018$0.50$0.65$1.15$311.84 million$325.30 millionListen
8/8/2018Q2 2018$0.31$0.48$1.16$275.51 million$302.84 millionN/A
5/9/2018Q1 2018$0.11$0.03$1.02$232.05 million$223.88 millionTranscript
2/28/2018Q4 2017$0.22$0.29$0.86$264.48 million$274.22 millionTranscript
11/6/2017Q3 2017$0.22$0.26$0.91$259.74 million$271.60 millionN/A
8/7/2017Q2 2017$0.12$0.41$2.11$237.01 million$289.51 millionListen
5/8/2017Q1 2017$0.25$0.21$0.98$248.71 million$220.90 millionListen
2/27/2017Q416$0.51$0.64$1.81$307.93 million$310.30 millionListen
11/7/2016Q316$0.63$0.70$1.16$270.04 million$273.70 millionListen
8/8/2016Q216$0.50$0.62$0.75$235.43 million$257.40 millionN/A
5/9/2016Q116$0.30$0.34$0.96$197.73 million$204.70 millionN/A
2/29/2016Q415$0.62$0.63$0.89$240.92 million$244.50 millionListen
11/6/2015Q315$0.41$0.59$1.16$185.70 million$292.70 millionListen
8/7/2015Q215$0.32$0.39$0.38$156.41 million$172.80 millionListen
5/8/2015Q115$0.22$0.16$0.48$104.20 million$113.10 millionN/A
2/27/2015Q414$0.23$0.27$0.81$95.50 million$103.80 millionN/A
11/6/2014Q314$0.19$0.24$0.36$73.17 million$75.10 millionN/A
8/7/2014Q214$0.16$0.14$0.66$58.35 million$66.10 millionN/A
5/9/2014Q114$0.01$0.10$3.27$42.69 million$51.90 millionN/A
3/13/2014Q4 2013($0.25)$1.06$32.20 million$43.10 millionN/A
11/8/2013Q3 2013($0.07)($0.06)$18.31 million$31.50 millionN/A
8/9/2013Q2 2013($0.26)($0.23)$16.09 million$17.64 millionN/A
5/10/2013Q1 2013($0.34)($0.32)$9.47 million$9.20 millionTranscript
3/18/2013Q4 2012($0.38)($0.36)N/A
11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionListen
8/10/2012Q2 2012($0.66)($0.64)N/A
5/10/2012Q1 2012($0.95)($0.92)N/A
3/23/2012Q4 2011($1.20)($3.91)($3.90)N/A
11/14/2011Q3 2011($0.94)($1.23)($1.16)N/A
8/31/2011Q2 2011($6.02)($4.26)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/1/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.